Cite
Supplementary Materials and Methods, Figure Legends, Tables 1 - 2 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts
MLA
Damien M. Cronier, et al. Supplementary Materials and Methods, Figure Legends, Tables 1 - 2 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts. Mar. 2023. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....76827ed468388af5771b3df533a9ebe7&authtype=sso&custid=ns315887.
APA
Damien M. Cronier, Lawrence M. Gelbert, Graham N. Wishart, Alfonso De Dios, Edward M. Chan, Richard P. Beckmann, Teresa Burke, Rose T. Ajamie, Shufen Cai, & Sonya C. Tate. (2023). Supplementary Materials and Methods, Figure Legends, Tables 1 - 2 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts.
Chicago
Damien M. Cronier, Lawrence M. Gelbert, Graham N. Wishart, Alfonso De Dios, Edward M. Chan, Richard P. Beckmann, Teresa Burke, Rose T. Ajamie, Shufen Cai, and Sonya C. Tate. 2023. “Supplementary Materials and Methods, Figure Legends, Tables 1 - 2 from Semi-Mechanistic Pharmacokinetic/Pharmacodynamic Modeling of the Antitumor Activity of LY2835219, a New Cyclin-Dependent Kinase 4/6 Inhibitor, in Mice Bearing Human Tumor Xenografts,” March. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....76827ed468388af5771b3df533a9ebe7&authtype=sso&custid=ns315887.